Skip to main content

Table 1 Patient baseline characteristics for switchers and continuers of the initial antipsychotic - analysis sample

From: Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

Characteristic Patients continuing with their initial antipsychotics (N = 376) Patients switching antipsychotics (N = 156) p-value
Male, % 66.5 51.9 .002
Age, mean (SD), y 42.6 (12.0) 42.8 (12.8) .877
Age of onset, mean (SD), y 22.8 (10.3) 22.6 (9.2) .802
Unemployed 79.0 78.9 .971
Race, %    
   Caucasian 54.8 53.9 .843
   African descent 33.0 34.0 .824
   Other 12.2 12.2 .986
Diagnosis, %    
   Schizophrenia 65.7 61.5 .362
   Schizoaffective 25.0 28.2 .443
   Schizophreniform 9.3 10.3 .735
Comorbidities, %    
   MDD 13.3 14.1 .805
   Anxiety 6.1 3.2 .171
   Substance abuse 32.2 25.8 .146
  Patients continuing with their initial antipsychotics (N = 376) Patients switching antipsychotics (N = 156) p-value
Baseline PANSS total, mean (SD) 88.9 (20.6) 84.5 (19.3) .023
Hospitalization in prior year 30.2 24.5 .191
  1. Abbreviations: MDD, major depressive disorder; PANSS, positive and negative syndrome scale.
  2. P-values based on chi-square and t-tests.